BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gennemark P, Trägårdh M, Lindén D, Ploj K, Johansson A, Turnbull A, Carlsson B, Antonsson M. Translational Modeling to Guide Study Design and Dose Choice in Obesity Exemplified by AZD1979, a Melanin-concentrating Hormone Receptor 1 Antagonist. CPT Pharmacometrics Syst Pharmacol 2017;6:458-68. [PMID: 28556607 DOI: 10.1002/psp4.12199] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
Number Citing Articles
1 Brings A, Borghardt JM, Skarbaliene J, Baader-Pagler T, Deryabina MA, Rist W, Scheuerer S. Modeling energy intake and body weight effects of a long-acting amylin analogue. J Pharmacokinet Pharmacodyn 2018;45:215-33. [PMID: 29170989 DOI: 10.1007/s10928-017-9557-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
2 Engle SE, Antonellis PJ, Whitehouse LS, Bansal R, Emond MR, Jontes JD, Kesterson RA, Mykytyn K, Berbari NF. A CreER mouse to study melanin concentrating hormone signaling in the developing brain. Genesis 2018;56:e23217. [PMID: 29806135 DOI: 10.1002/dvg.23217] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
3 Zhuk PF, Karakhim SO. Extreme properties of the initial rate of the four-stage reaction of enzyme catalyzed ATP hydrolysis. J Math Chem 2021;59:1785-807. [DOI: 10.1007/s10910-021-01262-2] [Reference Citation Analysis]